Marijuana Rescheduling Latest & Hill Reactions The Drug Report

We sit down with Jordan, our head of federal affairs, to dissect the implications of marijuana potentially moving to Schedule III. This seismic shift has the industry abuzz, with financial windfalls and NASDAQ listings in sight for players like Curaleaf, but it's not all green pastures. Listen closely as we explore the critical social justice issues that could be overshadowed by the allure of tax deductions and the upcoming budget hearing with DEA Administrator Ann Milgram, where the conversa...